{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Intra-Cellular Therapies Inc."},"Symbol":{"label":"Symbol","value":"ITCI"},"Address":{"label":"Address","value":"430 EAST 29TH STREET, NEW YORK, New York, 10016, United States"},"Phone":{"label":"Phone","value":"+1 646 440-9333"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders."},"CompanyUrl":{"label":"Company Url","value":"https://www.intracellulartherapies.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Robert E. Davis","title":"Chief Scientific Officer & Senior Vice President"},{"name":"Sharon L. Mates","title":"Chairman & Chief Executive Officer"},{"name":"Suresh Durgam","title":"Chief Medical Officer & Executive Vice President"},{"name":"Willie R. Earley","title":"Senior Vice President & Head-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}